Specialty Pharmacy

New study findings suggest that more at-risk individuals should take pre-exposure prophylaxis to prevent HIV.

In an effort to evaluate whether switching from a reference biologic to a biosimilar could lead to altered clinical outcome, a research team, led by Hillel Cohen, PhD, conducted a systematic literature review of all available switching studies.

Daclizumab (Zinbryta) may cause brain inflammation among patients with relapsing multiple sclerosis.

Biologic drug demonstrates efficacy in moderate-to-severe asthma.

Patients with colon cancer who regularly consumed tree nuts had a 46% improvement in disease-free survival.

Shiela Arquette, RPh, BS Pharm, Executive Director, National Association of Specialty Pharmacy, discusses how the organization has fought against direct and indirect remuneration fees on behalf of specialty pharmacies.

Current treatments for neurofibromatosis tumors may result in drug resistance.

Top news of the day from across the health care landscape.

The authors of the study acknowledged that there is much more to be understood about the factors that affect adolescents and young adults at high risk for contracting or transmitting HIV.

We all make important interventions as pharmacists, but we don’t make front page headlines.

Increase in Merkel cell carcinoma cases outpaces the rate of melanoma.

Top news of the week from Specialty Pharmacy Times.

The US Preventive Services Task Force recommends against ovarian cancer screening.

Top news of the day from across the health care landscape.

March is multiple sclerosis awareness month.

This weekly video program provides our readers with an in-depth review of the latest news, product approvals, FDA rulings, and more. Our Week in Review is a can't miss for the busy pharmacy professional.

ERK inhibitors may increase the efficacy of other anti-cancer drugs.

Research highlights the need for new prostate specific antigen testing guidelines.

Ozanimod evaluated as a treatment for multiple sclerosis and inflammatory bowel disease.

Men exposed to diesel exhaust at work may increase their risk of ALS by at least 20%.

Top news of the day from across the health care landscape.

PBMs currently operate in Arkansas with no government oversight

ZTlido (lidocaine topical system) shows superior adhesion compared with other topical non-opioid pain patches.

Accounting for potential drug resistance improve the treatment of cancer.

Amazon, Berkshire Hathaway, JP Morgan Chase partnership seeks to revolutionize health care.

Joy Gilbert, Vice President, Operations, US Bioservices, a part of AmerisourceBergen, speaks about the many considerations that have to be addressed when launching a novel rare disease drug in a specialty-naive market.

Specialty pharmacies must focus on the fundamentals of compassion and effective communication to offer the patient-centric support needed for patients with a rare disease.

Several new approaches may increase drug development efforts for rare diseases.

The data published analyzes findings from key studies evaluating taliglucerase alfa in patients with Gaucher disease.

Top news of the day from across the health care landscape.